Which Drugs the $50 Medicare Bridge Covers

The short answer

The Medicare GLP-1 Bridge covers three weight-management medications: Wegovy (all formulations), the Zepbound KwikPen, and Foundayo. It does not cover Ozempic or Mounjaro. If you were hoping to get Ozempic at the $50 Bridge price, that is the single most common misunderstanding about this program — so it is worth getting right before you call your doctor.

What the Bridge covers

From July 1, 2026 through December 31, 2027, eligible Medicare members pay a flat $50 for a one-month supply — the same at any dose — of:

Wegovy (semaglutide), all formulations
Zepbound (tirzepatide), the KwikPen formulation
Foundayo

These are the medications FDA-approved for weight management, which is what the Bridge is built around.

What the Bridge does not cover

Ozempic and Mounjaro are not in the Bridge. This surprises people, because Ozempic and Wegovy share the same active ingredient (semaglutide), and Mounjaro and Zepbound are both tirzepatide. The difference is what each drug is FDA-approved for: Ozempic and Mounjaro are approved for type 2 diabetes, while Wegovy and Zepbound are approved for weight management. Because the Bridge is a weight-management program, it uses the weight-management brands.

If you take Ozempic or Mounjaro for diabetes, that is handled through Medicare's regular Part D coverage — not the Bridge. A separate effort called the BALANCE Model is expanding GLP-1 access in Medicare and Medicaid more broadly; see Bridge vs the BALANCE Model for how the two differ.

Compounded versions are not covered

Only the FDA-approved brand-name medications above qualify. Compounded semaglutide or tirzepatide is not covered by the Bridge. Filling a compounded version means paying out of pocket and losing the $50 price.

What this means for you

If your goal is weight management, the Bridge covers Wegovy, Zepbound (KwikPen), or Foundayo at $50 a month — if you meet the eligibility rules.
Take the 2-minute eligibility quiz to see if you likely qualify.
For the full rules, see the Medicare GLP-1 guide.

Always confirm current details with your plan or at Medicare.gov before scheduling appointments.

Frequently asked questions

Is Ozempic covered by the $50 Medicare Bridge?

No. Ozempic is FDA-approved for type 2 diabetes, not weight management, so it is not part of the weight-loss Bridge. Ozempic for diabetes is covered through Medicare's regular Part D coverage instead.

Why is Wegovy covered but not Ozempic if they are the same drug?

Both are semaglutide, but they are approved for different uses. Wegovy is approved for weight management (which the Bridge covers) and Ozempic is approved for type 2 diabetes (which it does not).

Does the Bridge cover compounded semaglutide or tirzepatide?

No. Only the FDA-approved brand-name drugs — Wegovy, the Zepbound KwikPen, and Foundayo — qualify for the $50 Bridge price. Compounded versions are not covered.

Which GLP-1 Drugs the $50 Medicare Bridge Covers